Westfall Nicholas Michael
SEC CIK 1676780 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHE | CHEMED CORP | EVP | 0 | — | $28.50M | 27 | 2020-11-03 | 2025-08-04 |
Most active insiders at CHE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MCNAMARA KEVIN J | Pres, CEO, Dir | — | $7.63M |
| 2 | LINDELL ANDREA R | Dir | — | $602.6K |
| 3 | LEE SPENCER S | EVP | — | $541.0K |
| 4 | WALSH GEORGE J III | Dir | — | $218.9K |
| 5 | GRACE PATRICK P | Dir | — | $126.6K |
| 6 | Wherley Joel L | CEO - Vitas Healthcare | — | — |
| 7 | McCarthy Eileen P | Dir | — | — |
| 8 | Mount John Meredith Jr. | Dir | — | — |
| 9 | Judkins Brian C | VP, CLO | — | — |
| 10 | Heaney Christopher J | Dir | — | — |
Westfall Nicholas Michael made no open-market trades at CHE in the last 12 months.
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-04 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale | $421.91 | -10.0K | 0 | -100% | -$4.22M | |
| D | 2025-05-12 | 2025-05-09 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $569.70 | -23.0K | 10.0K | -70% | -$13.10M |
| DM | 2025-05-12 | 2025-05-09 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $451.72 | +26.1K | 23.1K | New | +$11.78M |
| DM | 2025-02-18 | 2025-02-14 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $553.39 | +1,473 | 7,582 | +24% | +$815.1K |
| D | 2025-02-18 | 2025-02-14 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $553.39 | -658 | 6,924 | -9% | -$364.1K |
| 2024-09-10 | 2024-09-09 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale | $569.35 | -1,713 | 6,109 | -22% | -$975.3K | |
| D | 2024-09-06 | 2024-09-04 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $471.74 | +15.3K | 21.4K | +251% | +$7.23M |
| D | 2024-09-06 | 2024-09-04 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $586.39 | -13.6K | 7,822 | -64% | -$7.99M |
| A | 2024-08-01 | 2024-07-30 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale | $561.58 | -2,000 | 6,109 | -25% | -$1.12M |
| 2024-07-31 | 2024-07-30 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale | $561.58 | -2,000 | 5,990 | -25% | -$1.12M | |
| D | 2024-02-20 | 2024-02-16 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $586.49 | -352 | 8,109 | -4% | -$206.4K |
| DM | 2024-02-20 | 2024-02-16 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $586.49 | +785 | 7,990 | +11% | +$460.4K |
| D | 2023-06-05 | 2023-06-01 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $413.19 | +12.7K | 20.3K | +165% | +$5.24M |
| D | 2023-06-05 | 2023-06-01 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale+OE | $533.70 | -12.7K | 7,676 | -62% | -$6.76M |
| D | 2023-06-01 | 2023-05-30 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale+OE | $540.34 | -1,330 | 6,346 | -17% | -$718.7K |
| D | 2023-06-01 | 2023-06-01 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $413.19 | +1,330 | 7,676 | +21% | +$549.5K |
| DM | 2023-02-22 | 2023-02-17 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $515.12 | +1,224 | 7,780 | +19% | +$630.5K |
| D | 2023-02-22 | 2023-02-17 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $515.12 | -548 | 7,676 | -7% | -$282.3K |
| D | 2022-11-04 | 2022-11-03 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $306.70 | +13.5K | 20.5K | +193% | +$4.14M |
| D | 2022-11-04 | 2022-11-03 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale+OE | $477.19 | -13.5K | 7,000 | -66% | -$6.44M |
| 2022-05-11 | 2022-05-10 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale | $500.10 | -1,432 | 7,000 | -17% | -$716.1K | |
| DM | 2022-02-23 | 2022-02-18 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $459.77 | +1,592 | 8,442 | +23% | +$732.0K |
| D | 2022-02-23 | 2022-02-18 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | F - Tax | $459.77 | -638 | 8,432 | -7% | -$293.3K |
| DM | 2021-11-05 | 2021-11-04 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $231.91 | +5,594 | 3,302 | New | +$1.30M |
| DM | 2021-11-05 | 2021-11-02+ | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale+OE | $486.48 | -5,594 | 6,060 | -48% | -$2.72M |
| D | 2021-11-05 | 2020-11-03 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | S - Sale+OE | $490.65 | -7,527 | 6,268 | -55% | -$3.69M |
| D | 2021-11-05 | 2020-11-03 | CHE | CHEMED CORP | Westfall Nicholas Michael | EVP | M - OptEx | $231.91 | +7,527 | 13.8K | +120% | +$1.75M |
Purchase Sale Sale after option exercise All abbreviations